BioCentury
ARTICLE | Company News

Witz among departing Sanofi execs

May 24, 2016 12:21 AM UTC

Sanofi (Euronext:SAN; NYSE:SNY) said three executives will leave the company, including EVP of Diabetes and Cardiovascular Pascale Witz. Last year, Sanofi had named Witz to the post as part of a global reorganization (see BioCentury Extra, July 15, 2015).

EVP of General Medicines and Emerging Markets Peter Guenter will take over the diabetes and cardiovascular unit, effective June 1. Olivier Charmeil, who is EVP of the company's Sanofi Pasteur vaccine unit, will take over Guenter's position. Sanofi Pasteur Head of Global Commercial Operations David Loew will become the unit's EVP and general manager. ...